Stockreport

Does Tango Therapeutics' (TNGX) CEO Transition Clarify or Complicate Its Precision Oncology Roadmap? [Yahoo! Finance]

Tango Therapeutics, Inc.  (TNGX) 
PDF Malte Peters, a physician with extensive oncology development and regulatory experience, became President and Chief Executive Officer. Alongside this leadership shift, [Read more]